Follicular Lymphoma Treatment Market to Exhibit Steadfast Growth During 2018-2026 by Global Top Players - Celgene, AbbVie Inc., Novartis, Amgen, Merck & Co. (MRK), Bayer AG’S, Roche, Johnson and Johnson, CTI Biopharma, Spectrum Pharmaceuticals and BMY

Lymphoma refers to the cancer of lymphatic system, which affects the cells of the immune system known as lymphocytes resulting in abnormal multiplication and growth of the cells. Lymphocytes are the white blood cells that protect the body from the infection. It is of two types, namely, Non-Hodgkin and Hodgkin lymphoma. Follicular lymphoma is a type of Non-Hodgkin Lymphoma that affects the lymphocytes. It is the most common indolent type of Non- Hodgkin lymphoma. Follicular lymphoma has symptoms such as enlargement of the lymph nodes in the neck, groin, and abdomen, shortness of breath, weight loss, night sweats, and fatigue.

Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/907

Rituximab A Monoclonal Antibody Used As A Therapeutic Agent Is Expected To Augment The Market Growth

The major factors contributing to the growth of global follicular lymphoma treatment market are the rising adoption of monoclonal antibodies for targeted therapies. According to the National Center for Biotechnology Information (NCBI), in 2016, monoclonal antibodies are considered as the successful therapeutics in the cancer treatment. The use of monoclonal antibodies is expected to overcome the side effects, which are generally exhibited by traditional therapies such as radiation and chemotherapy. Therefore, the monoclonal antibody such as rituximab, an anti-CD20 antibody can act as a potential therapeutic agent for the treatment of follicular lymphoma cancer. Moreover, an increase in the number of incidence of relapsed follicular lymphoma is also expected to drive the market growth as the number of relapse for the disease results in the same patient availing the treatment multiple times. However, the factors hindering the growth of follicular lymphoma treatment market are the availability of the drugs and the high cost of the treatment.

Follicular Lymphoma Treatment Market Taxonomy:

On the basis of treatment type, the global follicular lymphoma treatment market is segmented into:

Radiation
Targeted therapy
Chemotherapy
Monoclonal antibody
Stem cell transplant

On the basis of the end user, the global follicular lymphoma treatment market is segmented into:

Hospitals
Specialty centers
Clinics
Cancer Research Institutes

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/907

Key Players Operating The Follicular Lymphoma Treatment Market:

Some of the key players operating in the global follicular lymphoma treatment market include Roche, Spectrum Pharmaceuticals, Johnson and Johnson, CTI Biopharma, Celgene, AbbVie Inc., Novartis, Amgen, Merck & Co. (MRK), Seattle Genetics, Pharmacyclics/ Bristol-Myers Squibb (BMY), and Bayer AG’S.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.